UBS ETF Please confirm that you are resident in Switzerland to proceed.

ETF Comparison

UBS ETF (IE) MSCI ACWI SF UCITS ETF

ISIN IE00BYVDRF92
Replication Synthetic
Asset class Equities
Fee 0.21%

Select a fund for comparison

Name of fund

UBS (Irl) Fund Solutions plc – MSCI ACWI SF UCITS ETF

Share class

UBS (Irl) Fund Solutions plc – MSCI ACWI SF UCITS ETF (hedged to GBP) A-UKdis

ISIN

IE00BYVDRF92

Asset Class

Equities

Fund domicile

IE

Fund type

open-end

Benchmark

MSCI ACWI with Developed Markets 100% hedged to GBP Index

UCITS IV

yes

Launch date

24.09.2015

Currency of share class

GBP

Accounting year end

30 June

Replication methodology

Synthetic (Fully Funded + Total Return Swap)

  • The investment objective of the fund is to deliver the net total return performance of the MSCI ACWI with Developed Markets 100% hedged to GBP Index less costs.
  • The Fund replicates synthetically the index performance by investing in a swap.
  • The swap counterparty transfers collateral to the ETF in the form of G10 government bonds, supranational bonds and cash.
  • The fund is passively managed.

Flat fee p.a.

0.21%

Total expense ratio (TER) p.a.1)

0.21%

Distribution date

01.02.2021

Pay date

04.02.2021

Currency

GBP

Distribution

1.80

  • The Reference Index is a free float-adjusted market capitalization-weighted index that captures the large and mid cap representation of equities across developed and emerging markets countries, with a current aggregate of over 2,400 constituents The Reference Index is based on the MSCI Global Investable Market Indexes (GIMI) Methodology, further information on which is set out on the Index Provider's website detailed below.

Please consider that this performance comparison tool serves for illustration purposes only as it allows to compare any UBS ETF regardless its fund characteristics, investment objectives. Please note that certain comparisons might be insignificant or misleading due to markets, currencies, sectors or risk exposures that might not be comparable. Neither UBS AG nor any of its affiliates, its directors, employees or agents accepts any liability for any loss or damage arising out of the use of this tool.

For marketing and information purposes by UBS. UBS funds under Swiss, Luxembourg and Irish law. Representative in Switzerland for UBS funds established under foreign law: UBS Fund Management (Switzerland) AG, P.O. Box, CH-4002 Basel. Paying agent: UBS AG. Prospectuses, simplified prospectuses, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available free of charge from UBS AG,  P.O. Box, CH-4002 Basel or from UBS Fund Management (Switzerland) AG,  P.O. Box, CH-4002 Basel. The funds or securities referred to herein are not sponsored, endorsed, or promoted by the index providers, and the index providers bear no liability with respect to any such funds or securities or any index on which such funds or securities are based. The prospectus contains a more detailed description of the limited relationship the index providers have with the licensee and any related funds. Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document contains statements that constitute “forward-looking statements”, including, but not limited to, statements relating to our future business development. While these forward-looking statements represent our judgments and future expectations concerning the development of our business, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations. Source for all data and charts (if not indicated otherwise): UBS Asset Management

© UBS 2021. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.